No extension of Financial Year clarifies Finance Minister of India

 

The Ministry of Finance issued a clarification that the Financial Year has not been extended. The clarification was issued to clear the confusion about the extension of the Financial Year caused after a notification was released by the Government of India about the amendments in the Indian Stamp Act. After the notification was released many people misquoted it and a fake news was circulated on social media regarding the extension of the Financial Year. However, the government later made it clear that the notification is being misquoted and it does not talk about the extension of the Financial Year but pertains to amendment in the Indian Stamp Act.

What was the original notification? This is what the official notification read:

 Read more at:

MINISTRY OF FINANCE (Department of Revenue)

NOTIFICATION

New Delhi, the 30th March, 2020 S.O. 1226(E).

 —In exercise of the powers conferred by section 11 of the Finance Act, 2019 (7 of 2019), the Central Government hereby makes the following amendments in the notification of the Government of India, Ministry of Finance, published in the Gazette of India vide S.O. 115 (E), datedthe 8th January, 2020 namely:— In the said notification, for the words and figures “the 1st day of April 2020, the words, figures and letters “the 1st day of July 2020” shall be substituted. [F. No. S.33013/3/2019 ST-I, DOR] RITVIK PANDEY, Jt. Secy. Note : The principal notification was published in the Gazette of India, Extraordinary, Part II, Section 3, Sub-section (ii) vide number S.O. 4419 (E), dated the 10th December, 2019 and subsequently amended vide notification dated 8th January, 2020, published vide number S.O.115 (E) dated the 8th January, 2020.

Source From:- caclubindia.com

Read More

Hydroxychloroquine and azithromycin as a treatment of COVID-19? Results of an open-label non-randomized clinical trial

 Background

Chloroquine and hydroxychloroquine have been found to be efficient on SARS-CoV-2, and reported to be efficient in Chinese COV-19 patients. We evaluate the role of hydroxychloroquine on respiratory viral loads.

Patients and methods

French Confirmed COVID-19 patients were included in a single-arm protocol from early March to March 16^th, to receive 600mgof hydroxychloroquine daily and their viral load in nasopharyngeal swabs was tested daily in a hospital setting. Depending on their clinical presentation, azithromycin was added to the treatment. Untreated patients from another centre and cases refusing the protocol were included as negative controls. Presence and absence of virus at Day6-post inclusion was considered the endpoint.

Results

Six patients were asymptomatic, 22 had upper respiratory tract infection symptoms and eight had lower respiratory tract infection symptoms.

Twenty cases were treated in this study and showed a significant reduction of the viral carriage at D6-post inclusion compared to controls, and much lower average carrying duration than reported of untreated patients in the literature. Azithromycin added to hydroxychloroquine was significantly more efficient for virus elimination.

Conclusion

Despite its small sample size, our survey shows that hydroxychloroquine treatment is significantly associated with viral load reduction/disappearance in COVID-19 patients and its effect is reinforced by azithromycin.

Source From medium.com

Read More